Variant report
Variant | nsv979827 |
---|---|
Chromosome Location | chr3:45924432-45925432 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOXM1 | chr3:45925059-45925841 | GM12878 | blood: | n/a | n/a |
2 | MTA3 | chr3:45924851-45926904 | GM12878 | blood: | n/a | n/a |
3 | NFATC1 | chr3:45924804-45926829 | GM12878 | blood: | n/a | n/a |
4 | NFIC | chr3:45925190-45927089 | GM12878 | blood: | n/a | n/a |
5 | PML | chr3:45924828-45927210 | GM12878 | blood: | n/a | n/a |
6 | POLR2A | chr3:45925150-45925653 | GM12878 | blood: | n/a | n/a |
7 | RUNX3 | chr3:45925219-45925766 | GM12878 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:45922108..45924975-chr3:45933515..45935925,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FYCO1-3 | chr3:45925132-45925605 | NONHSAT089420 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CCR9 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535747958 | chr3:45924434-45924435 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368882773 | chr3:45924435-45924436 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183022170 | chr3:45924500-45924501 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539524120 | chr3:45924512-45924513 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557863678 | chr3:45924694-45924695 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187541113 | chr3:45924701-45924702 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548902838 | chr3:45924713-45924714 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540276316 | chr3:45924778-45924779 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6441929 | chr3:45924791-45924792 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs574216792 | chr3:45924816-45924817 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs544912195 | chr3:45924819-45924820 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs562919713 | chr3:45924823-45924824 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs533603876 | chr3:45924833-45924834 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs141942877 | chr3:45924851-45924852 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs576701738 | chr3:45924879-45924880 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs12631321 | chr3:45924897-45924898 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs150667470 | chr3:45924901-45924902 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs546235960 | chr3:45924910-45924911 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs6441930 | chr3:45924953-45924954 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs535357656 | chr3:45924964-45924965 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs192546544 | chr3:45924994-45924995 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs138421181 | chr3:45925170-45925171 | Bivalent Enhancer Weak transcription Genic enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs539286981 | chr3:45925173-45925174 | Bivalent Enhancer Weak transcription Genic enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs142760055 | chr3:45925178-45925179 | Bivalent Enhancer Weak transcription Genic enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs555662782 | chr3:45925270-45925271 | Bivalent Enhancer Weak transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs534316485 | chr3:45925290-45925291 | Bivalent Enhancer Weak transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs555447822 | chr3:45925322-45925323 | Bivalent Enhancer Weak transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs574009126 | chr3:45925345-45925346 | Bivalent Enhancer Weak transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs115004584 | chr3:45925363-45925364 | Bivalent Enhancer Weak transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs114039636 | chr3:45925382-45925383 | Bivalent Enhancer Weak transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Biliary cancer | 19435499 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Breast cancer | 21509527 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Gastric cancer | 16891809 | CNVD |
Night blindness | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 17297452 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:45916600-45925200 | Genic enhancers | Dnd41 | blood |
2 | chr3:45918400-45926000 | Weak transcription | Duodenum Mucosa | Duodenum |
3 | chr3:45923200-45928000 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
4 | chr3:45923400-45930000 | Weak transcription | Primary hematopoietic stem cells | blood |
5 | chr3:45923400-45932000 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
6 | chr3:45923400-45948200 | Weak transcription | Right Atrium | heart |
7 | chr3:45923600-45930200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr3:45924000-45925200 | Weak transcription | Thymus | Thymus |
9 | chr3:45924000-45925200 | Weak transcription | K562 | blood |
10 | chr3:45924000-45925400 | Weak transcription | GM12878-XiMat | blood |
11 | chr3:45924200-45925000 | Weak transcription | Fetal Thymus | thymus |
12 | chr3:45924200-45927400 | Weak transcription | Primary T cells from cord blood | blood |
13 | chr3:45925000-45925400 | Bivalent Enhancer | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr3:45925000-45927400 | Genic enhancers | Fetal Thymus | thymus |
15 | chr3:45925200-45925400 | Enhancers | K562 | blood |
16 | chr3:45925200-45925600 | Transcr. at gene 5' and 3' | Dnd41 | blood |
17 | chr3:45925200-45926000 | Enhancers | Thymus | Thymus |
18 | chr3:45925200-45949600 | Weak transcription | Pancreas | Pancrea |
19 | chr3:45925400-45925800 | Weak transcription | K562 | blood |
20 | chr3:45925400-45926400 | Enhancers | GM12878-XiMat | blood |